Methods and systems for pharmacy modeling

Patent metadata

Field	Value
Publication number	US-9773094-B1
Application number	US-201514612005-A
Country	US
Kind code	B1
Filing date	Feb 2, 2015
Priority date	Jan 31, 2014
Publication date	Sep 26, 2017
Grant date	Sep 26, 2017

Abstract

Methods and systems for pharmacy modeling are described. The risk adjusted pharmacy predictive model is created from member data, claims data, and population data. This model can be used to compare the actual pharmacy performance to an expected actual pharmacy performance value, which can be used to identify pharmacies at risk or not performing to an acceptable level. The model can be used for adherence and generic drug utilization ratings of pharmacies. The pharmacy can be judged on a therapy class by therapy class basis with factors that reflect the demographic, socio-economic, location, benefits attributes, etc. that actually affect the performance of the pharmacy and may assist in determining the quality of care by a pharmacy.

First claim

What is claimed is:

1. A method comprising:
accessing member data, claims data, and population data;
creating a pharmacy predictive model based on the member data, the claims data, and the population data;
determining a calculated adherence percentage for a therapy class at a pharmacy;
calculating an expected adherence percentage for the therapy class at the pharmacy using the pharmacy predictive model; and
comparing the calculated adherence percentage for the therapy class at the pharmacy to the expected adherence percentage for the therapy class at the pharmacy.

2. The method of claim 1 , wherein the therapy class includes at least one of the therapy class for antibiotics, antidepressants, antifungals, lipid lowering, narcotics & pain relief, thyroid, and ulcer and heartburn.

3. The method of claim 1 , wherein creating the pharmacy predictive model includes relating the member data to a particular pharmacy for use in creating the pharmacy model, wherein the member data includes demographic attributes of the member.

4. The method of claim 3 , wherein creating the pharmacy predictive model includes compiling data based on location of the particular pharmacy.

5. The method of claim 3 , wherein creating the pharmacy predictive model includes claims data relating to copay for drugs dispensed in the therapy class.

6. The method of claim 1 , wherein creating the pharmacy predictive model includes compiling a first set of factors to possibly relate to adherence at the pharmacy, reducing the first set of factors to a second set of factors that reflect only factors that influence pharmacy performance for adherence in the therapy class and including the second set of factors in the pharmacy predictive model.

7. The method of claim 6 , wherein creating the pharmacy predictive model includes assigning a weight to each of the factors in the second set of factors.

8. The method of claim 6 , wherein the second set of factors includes an average days supply per prescription factor.

9. The method of claim 6 , wherein the second set of factors includes an average chronic disease score for patients at a particular pharmacy factor and a member new to the therapy class factor.

10. The method of claim 1 , wherein creating the pharmacy predictive model includes excluding any pharmacy that fails to reach a minimum threshold of members.

11. The method of claim 1 , wherein determining a calculated adherence percentage includes members who have at least two pharmacy claims in the therapy class.

12. A method comprising:
accessing member data, claims data, and population data;
determining a calculated generic dispensing ratio for a therapy class at a pharmacy;
calculating an expected generic dispensing ratio for the therapy class at the pharmacy using a pharmacy predictive model; and
comparing the calculated generic dispensing ratio for the therapy class at the pharmacy to the expected generic dispensing ratio percentage for the therapy class at the pharmacy.

13. The method of claim 12 , wherein the member data include average age of patients at the pharmacy and a level of income in an area at which the pharmacy is located, and wherein determining includes using pharmacy location to determine the calculated generic dispensing ratio and wherein calculating the expected generic dispensing ratio includes using pharmacy location to calculate the expected generic dispensing ratio.

14. The method of claim 13 , wherein the pharmacy predictive model includes a variable of a ratio of the therapy class versus activity at the pharmacy.

15. The method of claim 14 , wherein the therapy class is one of includes a variable of ADHD, Allergy, Antianxiety, Antibiotics, Antidepressants, Antifungals, Antivirals, Asthma & COPD, Cough & Cold, Dermatological, Diabetes, Ear, Nose & Throat, Hormone Replacement, Hypertension, Lipid lowering, Ophthalmological and Urological.

16. The method of claim 12 , wherein creating the generic dispensing ratio predictive model includes compiling a first set of factors to possibly relate to generic dispensing ratio at the pharmacy, reducing the first set of factors to a second set of factors that reflect only factors that influence pharmacy performance for generic dispensing ratio in the therapy class and including the second set of factors in the pharmacy predictive model, and wherein the second set of factors includes an average days supply per prescription Rx proportion of claims with prior authorization factor.

17. The method of claim 12 , wherein creating the pharmacy predictive model includes compiling a first set of factors to possibly relate to generic dispensing ratio at the pharmacy, reducing the first set of factors to a second set of factors that reflect only factors that influence pharmacy performance for the generic dispensing ratio and including the second set of factors in the risk adjusted pharmacy predictive model.

18. The method of claim 12 , wherein creating the pharmacy predictive model includes excluding any pharmacy that fails to reach a minimum threshold of members.

Assignees

• Express Scripts Inc

Inventors

• Balagere Dhanur S
• Tomala David A
• Nease Robert F
• Iyengar Reethi N

Classifications

• G06Q10/06395

  Quality analysis or management · CPC title

• G06Q10/0637

  Strategic management or analysis, e.g. setting a goal or target of an organisation; Planning actions based on goals; Analysis or evaluation of effectiveness of goals · CPC title

• G06Q10/0633

  Workflow analysis · CPC title

• G16H40/20

  for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms · CPC title

• G06Q10/06

  Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling · CPC title